Drug intelligence / Profile preview

stx140

Development stage
Preclinical
Lead developer
Ipsen
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

STX140 is a synthetic steroidal compound belonging to the estrane steroid class. It is a bis-sulfamoylated derivative of 2-methoxyestradiol and acts as a multitargeted anticancer agent. Its primary mechanisms include potent inhibition of carbonic anhydrase II and steroid sulfatase (STS), as well as antiproliferative and antiangiogenic activities demonstrated in preclinical models. STX140 has shown significant tumor growth inhibition in xenograft models and exhibits activity across multiple cancer cell lines[1][5][7]. The compound was developed by researchers at the University of Bath in collaboration with Sterix Ltd[5].

Other names
(9beta,13alpha,14beta,17alpha)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl disulfamate
02

Targets

CA2 (Carbonic Anhydrase 2)STS (Steroid sulfatase)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on stx140.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on stx140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call